Pfm Health Sciences, LP Alkermes Plc. Transaction History
Pfm Health Sciences, LP
- $1.53 Billion
- Q4 2024
A detailed history of Pfm Health Sciences, LP transactions in Alkermes Plc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 80,719 shares of ALKS stock, worth $2.23 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
80,719
Previous 205,073
60.64%
Holding current value
$2.23 Million
Previous $5.74 Million
59.56%
% of portfolio
0.15%
Previous 0.34%
Shares
5 transactions
Others Institutions Holding ALKS
# of Institutions
386Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$805 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$512 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$339 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$244 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$209 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.54B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...